• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

R.A.Erez Systems Ltd. Commences Study of the Automated CPR Device at Hadassah Hospital

Posted on: Tuesday, 17 July 2007, 09:04 CDT

R.A.Erez Systems Ltd. announced today that the company has commenced a study of its flagship product, an automated CPR device, at Hadassah Hospital in Ein Kerem, Jerusalem, Israel. The mechanized device enables continuous compressions, at pressure and rate levels based on the real time physiological state of a patient. It also monitors the performance of the device and the progress of the patient.

Several clinical studies have shown that applying an interposed compression cycle to both the chest and abdominal areas has significant hemodynamic advantages to the resuscitation process and may increase chances of patient survival. In addition, The American Heart Association guidelines published in November 2005 call for rapid, minimally interrupted chess compressions.

"It is my belief that a mechanical device able to maintain a high rate of deep, uninterrupted compressions over a long period of time can become a useful tool in improving future resuscitation processes. I believe the R.A.Erez Automated CPR device will have merit from both the medical and potentially commercial point of view," said cardiologist Karl B. Kern, MD, Professor of Medicine, University of Arizona, Sarver Heart Center.

Current CPR protocol entails deep, two inch depth compressions to the chest at a rate of 100 per/minute. The administration of CPR can last as long as 20 minutes. Studies show that when CPR is administered manually by a rescuer, even a trained health worker, the rate and pressure of the CPR drops after the second minute. Also, without equipment, it is also impossible to monitor performance.

"There are other mechanized CPR devices on the market. However, the force and rate of compressions applied by these machines are the same for all, be the patient a 65-year-old female with osteoporosis or a fit 25-year-old male. The added value of the R.A.Erez automated CPR device is that it first defines the physiological characteristics of the patient's ribcage. Then it sets the conformed level of forces and frequency which are necessary to delivering an optimal chest compressions treatment for each individual subject," said Nadav Malchi, CEO of R.A.Erez Systems Ltd.

The pre-clinical study will be conducted at the Heart Institute at Hadassah, Professor Chaim Lotan, Chairman, and will test the electrodynamic parameters of the second prototype of the Automated CPR device. The results will serve as a basis for the third prototype that the company plans to develop in line with FDA guidelines and intends to submit for a 510K approval. The R.A.Erez management is open to discussions with potential partners.

For more information, please visit http://www.erez-sys.com. To schedule an appointment or an interview with the R.A.Erez Systems management, please contact media liaison Marjie Hadad at +972-54-536-5220 or at marjie@netvision.net.il.

Source: Business Wire

More News in this Category